Dec-92 -

Radiation Oncology Group

EORTC 22791 – Phase III trial of twice daily fractions versus single daily fraction radiotherapy in oropharyngeal carcinoma.

EORTC found that high-dose radiotherapy was better than low-dose at local control and prolonging survival in patients with advanced oropharyngeal cancers.

READ MORE

Go to Top